2020Modern Approaches in Drug DesigningOpen access

Chloroquine and Hydroxychloroquine in the Management of Coronavirus: Cares and Challenges

Ahmed M Abu Dief

Open full text 2 citations

Abstract

It is clear enough at this time that vaccines will not be available at least for the few months to came. An association between an antibiotic (Azithromycin) and an antimalarial drug (chloroquine) has already been tested.

Open-access reader

About this research paper

What this paper is about

It is clear enough at this time that vaccines will not be available at least for the few months to came. An association between an antibiotic (Azithromycin) and an antimalarial drug (chloroquine) has already been tested.

Why it matters

OpenAlex reports 2 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

It is clear enough at this time that vaccines will not be available at least for the few months to came. An association between an antibiotic (Azithromycin) and an antimalarial drug (chloroquine) has already been tested.

Key concepts: Hydroxychloroquine, Chloroquine, Azithromycin, Virology, Coronavirus disease 2019 (COVID-19), Coronavirus, Medicine, Malaria

Related papers

Back to paper searchBrowse research topicsOriginal source
Chloroquine and Hydroxychloroquine in the Management of Coronavirus: Cares and Challenges — Research Paper | ScholarLens